These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 37952790)
1. Implantable cardioverter defibrillators for primary prevention in patients with ischemic and non-ischemic cardiomyopathy: A meta-analysis. Jaiswal V; Taha AM; Joshi A; Deb N; Kanagala SG; Nebuwa C; Ang SP; Halder A; Rajak K; Jha M; Pallath Harshakumar S; Mattumpuram J Curr Probl Cardiol; 2024 Feb; 49(2):102198. PubMed ID: 37952790 [TBL] [Abstract][Full Text] [Related]
2. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis. Akel T; Lafferty J Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469 [TBL] [Abstract][Full Text] [Related]
3. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. Stavrakis S; Asad Z; Reynolds D J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104 [TBL] [Abstract][Full Text] [Related]
4. Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis. Kolodziejczak M; Andreotti F; Kowalewski M; Buffon A; Ciccone MM; Parati G; Scicchitano P; Uminska JM; De Servi S; Bliden KP; Kubica J; Bortone A; Crea F; Gurbel P; Navarese EP Ann Intern Med; 2017 Jul; 167(2):103-111. PubMed ID: 28632280 [TBL] [Abstract][Full Text] [Related]
5. Role of implantable cardioverter defibrillator in non-ischemic cardiomyopathy: a systematic review and meta-analysis of prospective randomized clinical trials. Romero J; Chaudhary R; Garg J; Lupercio F; Shah N; Gupta R; Nazir T; Bozorgnia B; Natale A; Di Biase L J Interv Card Electrophysiol; 2017 Sep; 49(3):263-270. PubMed ID: 28674918 [TBL] [Abstract][Full Text] [Related]
6. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. Desai AS; Fang JC; Maisel WH; Baughman KL JAMA; 2004 Dec; 292(23):2874-9. PubMed ID: 15598919 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions. Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517 [TBL] [Abstract][Full Text] [Related]
8. Cardioverter-defibrillator reduces mortality risk in eligible ischemic and non-ischemic cardiomyopathy patients: Sub-analysis of the multi-center Improve SCA study. Singh B; Hsieh YC; Liu YB; Lin KH; Joung B; Rodriguez DA; Chasnoits AR; Huang D; Zhang S; O'Brien JE; Lexcen DR; Cerkvenik J; Van Dorn B; Ching CK Indian Heart J; 2023; 75(2):115-121. PubMed ID: 36736459 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of Implantable Cardioverter-Defibrillator Therapy in Patients With Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Anantha Narayanan M; Vakil K; Reddy YN; Baskaran J; Deshmukh A; Benditt DG; Adabag S JACC Clin Electrophysiol; 2017 Sep; 3(9):962-970. PubMed ID: 29759721 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis. Siddiqui WJ; Aggarwal S; Rafique M; Singh S; Kutalek S; Eisen HJ Heart Fail Rev; 2018 Mar; 23(2):181-190. PubMed ID: 29380177 [TBL] [Abstract][Full Text] [Related]
12. Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials. Barakat AF; Saad M; Elgendy AY; Mentias A; Abuzaid A; Mahmoud AN; Elgendy IY BMJ Open; 2017 Jun; 7(6):e016352. PubMed ID: 28637742 [TBL] [Abstract][Full Text] [Related]
13. The mortality for the implantable cardiac defibrillator in nonischemic cardiomyopathy: An updated systematic review and meta-analysis. He W; Xue C; Zheng J; Shuai Z Clin Cardiol; 2022 Dec; 45(12):1163-1170. PubMed ID: 36056632 [TBL] [Abstract][Full Text] [Related]